Why the study?
To summarize the evidence underlying a novel 5-year arrhythmic risk calculator algorithm in ARVC and discuss its clinical implementation for individualized SCD prevention.
Does the ARVC risk calculator improve individualized arrhythmic risk stratification for primary prevention ICD placement in patients with ARVC?
Does the ARVC risk calculator improve individualized arrhythmic risk stratification for primary prevention ICD placement in patients with ARVC?
Answers are grounded in this paper and cite their sources.
The ARVC risk calculator is a clinically validated tool that provides superior, individualized 5-year arrhythmic risk estimates to guide primary prevention ICD placement compared to previous expert consensus guidelines.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable cardiomyopathy characterized by a predominantly arrhythmic presentation. It represents the leading cause of sudden cardiac death (SCD) among athletes and poses a significant morbidity threat in the general population. As a causative treatment for ARVC is still not available, the placement of an implantable cardioverter defibrillator represents the current cornerstone for SCD prevention in this setting. Thanks to international ARVC-dedicated efforts, significant steps have been achieved in recent years towards an individualized, patient-centred risk stratification approach. A novel risk calculator algorithm estimating the 5-year risk of arrhythmias of patients with ARVC has been introduced in clinical practice and subsequently validated. The purpose of this article is to summarize the body of evidence that has allowed the development of this tool and to discuss the best way to implement its use in the care of an individual patient.
No takes yet. Share an insight, caveat, or question.
Gasperetti et al. (2023) conducted a review in Arrhythmogenic right ventricular cardiomyopathy (ARVC). ARVC risk calculator vs. Traditional consensus guidelines (e.g., 2015 ITFC, 2017 AHA, 2019 HRS) was evaluated on 5-year risk estimation for a composite outcome of sustained VTs, ventricular fibrillation/flutter, sudden cardiac death, and appropriate ICD therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: